This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, resistance to chemotherapy. reviews various CTCs ct studies in the literature about their applications gynecological cancers. Hopefully, further translational research gynecology will enable...
